Avanos Medical, Inc. Completes Merger, Enters New Credit Agreement

What Happened

• Avanos Medical, Inc. announced the closing of a previously disclosed merger (Effective/Closing Date July 27, 2026) and consequential corporate and financing changes. Concurrent with the merger closing, Avanos repaid all loans and terminated all commitments under its prior Credit Agreement (dated June 24, 2022; amended June 26, 2024). The company entered into a new Credit Agreement dated July 27, 2026, naming Golub Capital Markets LLC as term loan administrative and collateral agent and Ally Bank as revolving administrative agent. At the Effective Time, Avanos’ Certificate of Incorporation and Bylaws were amended and restated in their entirety (copies filed as Exhibits 3.1 and 3.2).

Key Details

• Merger closed and related actions took place on or about July 27, 2026.
• Prior Credit Agreement (June 24, 2022; 1st amendment June 26, 2024) was fully repaid and terminated at closing.
• New Credit Agreement dated July 27, 2026 (Exhibit 10.1) lists Golub Capital Markets LLC (term loan agent) and Ally Bank (revolving agent).
• Certificate of Incorporation and Bylaws were amended and restated at the Effective Time (Exhibits 3.1 and 3.2).
• The filing includes a press release dated July 27, 2026 (Exhibit 99.1) and references changes in control and director/officer matters incorporated by reference to the Introductory Note.

Why It Matters

• For investors, the filing confirms a change in control and refreshed corporate governance documents, which can affect corporate authority and shareholder rights.
• The new credit agreement replaces the prior debt facility; while terms are not summarized in the 8‑K text, the financing change can affect Avanos’ liquidity profile and future interest/repayment obligations.
• The press release and the filed exhibits provide the primary public details; shareholders should review Exhibits 3.1, 3.2, 10.1 and the press release for the full terms and any disclosed leadership or listing changes.